BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miró-Canturri A, Ayerbe-Algaba R, Vila-Domínguez A, Jiménez-Mejías ME, Pachón J, Smani Y. Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli. Antibiotics (Basel) 2021;10:336. [PMID: 33810067 DOI: 10.3390/antibiotics10030336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Miró-Canturri A, Vila-Domínguez A, Caretero-Ledesma M, Ayerbe-Algaba R, Pachón J, Jiménez-Mejías ME, Smani Y. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections. Microbiol Spectr 2021;9:e0040321. [PMID: 34668743 DOI: 10.1128/Spectrum.00403-21] [Reference Citation Analysis]
2 Krátký M, Konečná K, Brablíková M, Janoušek J, Pflégr V, Maixnerová J, Trejtnar F, Vinšová J. Iodinated 1,2-diacylhydrazines, benzohydrazide-hydrazones and their analogues as dual antimicrobial and cytotoxic agents. Bioorg Med Chem 2021;41:116209. [PMID: 34015704 DOI: 10.1016/j.bmc.2021.116209] [Reference Citation Analysis]
3 Miró-Canturri A, Ayerbe-Algaba R, Vila-Domínguez A, Jiménez-Mejías ME, Pachón J, Smani Y. Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli. Antibiotics (Basel) 2021;10:336. [PMID: 33810067 DOI: 10.3390/antibiotics10030336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]